Diaceutics (LON:DXRX) Stock Price Crosses Below 50-Day Moving Average – Here’s What Happened

Diaceutics PLC (LON:DXRX) shares passed below its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of GBX 187.36 and traded as low as GBX 178.50. Diaceutics shares last traded at GBX 184, with a volume of 151,555 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group reissued a “buy” rating and set a GBX 215 target price on shares of Diaceutics in a research report on Tuesday. Two equities research analysts have rated the stock with a Buy rating. According to data from MarketBeat, Diaceutics presently has a consensus rating of “Buy” and a consensus target price of GBX 215.

Diaceutics Price Performance

The firm has a 50-day simple moving average of GBX 187.36 and a two-hundred day simple moving average of GBX 160.73. The company has a market capitalization of £160.17 million, a price-to-earnings ratio of -589.06 and a beta of 0.88. The company has a current ratio of 2.55, a quick ratio of 9.92 and a debt-to-equity ratio of 5.40.

Diaceutics (LON:DXRX) last issued its quarterly earnings data on Tuesday, September 22nd. The company reported GBX (3.27) earnings per share (EPS) for the quarter. Diaceutics had a negative net margin of 0.66% and a negative return on equity of 0.68%. As a group, analysts predict that Diaceutics PLC will post 1.01 earnings per share for the current fiscal year.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.